Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank71
3Y CAGR-19.5%
5Y CAGR+11.6%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-19.5%/yr
vs +52.0%/yr prior
5Y CAGR
+11.6%/yr
Recent deceleration
Acceleration
-71.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.16M | -24.2% |
| 2024 | $20.00M | -17.8% |
| 2023 | $24.34M | -16.2% |
| 2022 | $29.05M | -18.0% |
| 2021 | $35.44M | +304.5% |
| 2020 | $8.76M | +67.3% |
| 2019 | $5.24M | -3.7% |
| 2018 | $5.43M | -31.4% |
| 2017 | $7.92M | +702.3% |
| 2016 | $987475.00 | - |